Results 241 to 250 of about 3,917,874 (426)

Peroxisome Proliferator-Activated Receptor-δ Genotype Influences Metabolic Phenotype and May Influence Lipid Response to Statin Therapy in Humans: A Genetics of Diabetes Audit and Research Tayside Study [PDF]

open access: bronze, 2010
Lindsay Burch   +9 more
openalex   +1 more source

GM2 activator deficiency: An ultra-rare disorder with a new case and review of 22 published cases. [PDF]

open access: yesMol Genet Metab Rep
Yoldaş Çelik M   +3 more
europepmc   +1 more source

Objectives and activities of the Genetic Alliance [PDF]

open access: yesAmerican Journal of Public Health, 2000
M E Davidson, J Weiss
openaire   +2 more sources

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

open access: yesMolecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit   +19 more
wiley   +1 more source

The Relationship between Peroxisome Proliferator-Activated Receptor-γ and Renin: A Human Genetics Study [PDF]

open access: bronze, 2010
Patricia Underwood   +11 more
openalex   +1 more source

Interstitial stem cells in Hydra [PDF]

open access: yes, 1987
Bosch, Thomas C. G.   +5 more
core  

Interplay of integrins and selectins in metastasis

open access: yesMolecular Oncology, EarlyView.
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy